Skip to main content
Home
Search
Multi-scale Atlas
NEW
Search for Drug ADMET Endpoint Profile (DAE)
NEW
Search for Drug Pharmacogenomic Perturbation Map (DPP)
NEW
Search for Drug-Molecule Activity Atlas (DMA)
NEW
Drug Development Portfolio
Search for Drug
Search for Combinatorial Drug (CBD)
Search for Repurposed Drug (RPD)
Drug-interacting Molecule
Search for Drug Therapeutic Target (DTT)
Search for Drug Transporter (DTP)
Search for Drug-Metabolizing Enzyme (DME)
Search for Drug Off-target (DOT)
Disease
Search for Disease
Download
Help
About
Details of the Drug Formulaction
General Information of Drug Formulation (ID: F23425)
Formulation Name
Disopyramide Phosphate eq 100mg base capsule
Company
Pfizer Laboratories Div Pfizer
Pharmaceutical Drug(s) in Formulation
Drug Name
Drug ID
Indication
ICD 11
Status
Disopyramide
DM5SYZP
Long QT syndrome
BC65.0
Approved
--------------------
Pharmaceutical Excipient(s) in Formulation
Excipient Name
Excipient ID
PubChem CID
Functional Classification
Beta-D-lactose
E00099
6134
Diluent; Dry powder inhaler carrier; Lyophilization aid
Erythrosine sodium anhydrous
E00324
27872
Colorant
Gelatin
E00630
Not Available
Other agent
Pregelatinized starch
E00674
Not Available
Binding agent; Diluent; Disintegrant
Sunset yellow FCF
E00255
17730
Colorant
Talc
E00520
16211421
Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide
E00322
26042
Coating agent; Colorant; Opacifying agent
--------------------